Liver disease

Study Links Spinal Muscular Atrophy to Increased Risk of Fatty Liver Disease

Recent international study reveals a concerning link between Spinal Muscular Atrophy (SMA) and an increased risk of fatty liver disease. SMA patients may face liver dysfunction due to reduced SMN protein levels, leading to fat accumulation and inflammation. Editing faulty genes to boost SMN production could reverse liver issues in SMA patients, highlighting the importance of monitoring and addressing liver health in this population.

Facial Temperatures as Key Indicator of Health Conditions Revealed in New Study

Facial temperatures can indicate underlying health conditions, with variations linked to chronic illnesses like diabetes and high blood pressure. A study in Cell Metabolism shows AI-derived spatial temperature patterns can detect these differences. Researchers aim to use thermal imaging for early disease detection and intervention, promoting healthy aging and disease prevention.

FDA Approves New Drug Iqirvo for Autoimmune Liver Disease Treatment

The FDA has approved a new drug, Iqirvo (elafibranor), for treating autoimmune liver disease, specifically primary biliary cholangitis (PBC). PBC can lead to liver damage or failure if left untreated, making early detection crucial. Iqirvo offers a targeted therapeutic approach to manage PBC and prevent complications, marking a significant advancement in autoimmune liver disease treatment.

AusperBio to Unveil Groundbreaking Clinical Data Updates at EASL Congress 2024

AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. are set to present groundbreaking clinical data updates on their molecule AHB-137 at the EASL™ Congress 2024. The Phase I trials focus on achieving a functional cure for chronic hepatitis B, a prevalent liver disease affecting millions globally. Learn more about the innovative research efforts at the official EASL™ Congress website.

WHO Warns of Deadly Hepatitis E Outbreak in Chad

The World Health Organisation (WHO) has issued a warning after an outbreak of Hepatitis E killed seven people in Chad, central Africa. More than 2,000 suspected cases have been reported, with the virus being prominent in the Ouaddai province due to an influx of refugees from Sudan. Doctors Without Borders has expressed concerns about the health risks posed to both refugees and host communities. Hepatitis E is highly contagious and mainly transmitted through contaminated water.

Hepatitis Awareness Month: Promoting Screening and Vaccination

Learn more about Hepatitis Awareness Month and how the CDC is promoting screening and vaccination efforts to combat viral hepatitis. Find out about Hepatitis Testing Day on May 19 and the key themes for this year’s awareness campaign. Join the conversation by sharing social media content and using hashtags like #HepAware2024 and #HepatitisAwarenessMonth.

New Study Shows Ozempic and Semaglutide May Lower Risk of Severe Liver Diseases

A nationwide study in Sweden suggests that GLP1 agonists like Ozempic could lower the risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. This new finding provides a potential life-saving benefit of these medications, offering a new treatment option for preventing severe liver diseases.

Everyday Foods That Can Contribute to Liver Damage

The liver is a vital organ that plays a crucial role in detoxification, metabolism, and nutrient storage. While alcohol is commonly known to be harmful to the liver, there are several everyday foods that can also contribute to liver damage…

Signs of Liver Damage: Foot Pain and Swelling

New Delhi: The liver is a vital organ that performs over 500 functions in the body, including digestion, blood cleaning, immune support, and blood clotting. When the liver is unable to carry out these functions, it may exhibit warning signs…